PHSRX Fees and Costs — Putnam Global Health Care Fund, Class R
Data updated: 2026-07-27
The net expense ratio is 1.29%: a 0.60% management fee, a 0.50% 12b-1 fee plus 0.19% other expenses. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $2.0M in broker commissions, 0.1224% of average net assets, and portfolio turnover was 67%.
PHSRX Fees and Expenses
Annual operating expenses and sales charges of PHSRX. Prospectus, as of August 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.60% |
| 12b-1 fee | 0.50% |
| Other expenses | 0.19% |
| Gross expense ratio | 1.29% |
| Fee waiver | — |
| Net expense ratio | 1.29% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
PHSRX Costs Over Time
On $10,000 invested in PHSRX, assuming 5% a year before costs, total costs come to $876 over 5 years, cutting the return by 1.48% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.29%) | $135 | $421 | $727 |
| Trading costs (broker commissions) | $13 | $40 | $69 |
| Lost growth on money paid in costs | $0 | $23 | $81 |
| Total costs | $148 | $484 | $876 |
| Value after costs | $10,352 | $11,093 | $11,887 |
| Impact on return, per year | 1.48% | 1.48% | 1.48% |
PHSRX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.1224%
- Total broker commissions: $2.0M
- Bought from dealers (principal trades, not a cost): $37.4M
- Portfolio turnover (prospectus): 67%
- Securities on loan, average value: $12.3M
- Net income from securities lending: $31K (0.002% of average net assets)
PHSRX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Jefferies LLC | $252K | 16.58% |
| UBS Securities LLC | $228K | 15.03% |
| Stifel, Nicolaus & Company, Incorporated | $196K | 12.88% |
| Goldman Sachs & Co. LLC | $168K | 11.05% |
| Citigroup Global Markets Inc. | $149K | 9.82% |
| BofA Securities, Inc. | $122K | 8.03% |
| Barclays Capital, Inc. | $120K | 7.91% |
| Cowen and Company | $111K | 7.32% |
| JonesTrading Institutional Services LLC | $103K | 6.77% |
| Piper Sandler & Co. | $70K | 4.60% |
PHSRX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BMO Capital Markets Corp. | $13.0M | 35.20% |
| Barclays Capital, Inc. | $5.4M | 14.61% |
| J.P. Morgan Securities LLC | $5.1M | 13.75% |
| Morgan Stanley & Co. LLC | $3.5M | 9.40% |
| Jefferies LLC | $3.3M | 8.86% |
| CanAccord Genuity LLC | $2.1M | 5.71% |
| Citigroup Global Markets Inc. | $1.6M | 4.30% |
| Goldman Sachs & Co. LLC | $1.5M | 3.95% |
| Nomura Securities International, Inc. | $888K | 2.41% |
| BofA Securities, Inc. | $667K | 1.81% |
Putnam Global Health Care Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| C000221197 | Class R6 | 0.70% | none |
| PHSYX | Class Y | 0.79% | none |
| PHSTX | Class A | 1.04% | 5.75% |
| PHSRX | Class R | 1.29% | none |
| PCHSX | Class C | 1.79% | none |
| PHSBX | Class B | 1.82% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.